ARYx Therapeutics, Inc. Share Price

ARYX

US0433871094

Biotechnology & Medical Research

Market Closed - OTC Markets 07:17:07 26/06/2023 pm IST			5-day change	1st Jan Change
0.001200 ^USD	+1,100.00%		+1,19,900.00%	+1,19,900.00%

1 week	+1,19,900.00%
Current month	+1,19,900.00%

Valuation : ARYx Therapeutics, Inc.

Market Cap	90.35L 77.55L 72.78L 66.48L 1.25Cr 86Cr 1.26Cr 8.61Cr 3.34Cr 43Cr 3.39Cr 3.32Cr 143.99Cr	P/E 2008	-1.76x	P/E 2009	-2.66x
Enterprise Value	1.14Cr 97.9L 91.88L 83.92L 1.58Cr 108.79Cr 1.59Cr 11Cr 4.21Cr 55Cr 4.28Cr 4.19Cr 181.77Cr	EV / Sales 2008	40,19,605x	EV / Sales 2009	-
Free-Float	100%	Yield 2008 *	-	Yield 2009	-

* Estimated data More valuation ratios

Press Releases : ARYx Therapeutics, Inc.

10/11/10	ARYX THER : ARYx Therapeutics Informed of Additional Delay by FDA and Begins Wind-Down of Operations	BU
24/10/24	ARYX THER : ARYx Therapeutics Clarifies Current Status of Operations	BU
21/10/21	ARYX THER : ARYx Therapeutics to Transfer to the NASDAQ Capital Market	BU
16/10/16	ARYX THER : ARYx Therapeutics Provides Update on Company Status	BU
15/10/15	ARYX THER : ARYx Therapeutics Reports Third Quarter Results	BU

More press releases

ARYx Therapeutics, Inc. is a United States-based pharmaceutical Company. The Company is developing a proprietary portfolio of patient-targeted, first-in-class monoclonal antibodies designed to treat seriously ill patients with difficult-to-treat diseases. It is engaged in retrometabolic drug design that focuses on the safety of oral therapies for chronic disease. The Companys clinical compounds include naronapride (ATI-7505) for gastrointestinal disorders; budiodarone (ATI-2042, for the treatment of atrial fibrillation; tecarfarin (ATI-5923) for the treatment of anticoagulation; and ATI-9242, for psychiatric disorders.

Employees

Sector

Biotechnology & Medical Research

More about the company

Stock Market
Stocks
ARYX Stock

As early as today, start finding the best investment opportunities!

3 years	0		0
5 years	0		0
10 years	0		0.05

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
ARYX THERAPEUTICS, INC.	+1,100.00%	+1,19,900.00%	+1,19,900.00%	+1,19,900.00%	33
WUXI APPTEC CO., LTD.	+3.31%	-3.70%	+61.03%	+103.64%	7.04TCr
ARGENX SE	+0.67%	+2.08%	+48.72%	+92.42%	6.54TCr
BIONTECH SE	-1.31%	-0.50%	+7.41%	-4.29%	2.83TCr
WUXI BIOLOGICS (CAYMAN) INC.	-0.49%	+1.73%	+59.01%	+11.60%	2.66TCr
INSMED INCORPORATED	+0.40%	-4.80%	-5.89%	+469.55%	2.72TCr
GENMAB A/S	+0.09%	+0.93%	+36.17%	-17.83%	2.01TCr
PHARMAESSENTIA CORPORATION	+1.02%	+6.43%	+269.42%	+420.34%	2.06TCr
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.	+0.77%	-1.59%	+13.19%	+543.56%	1.59TCr
EXELIXIS, INC.	-1.09%	+3.14%	+46.32%	+155.12%	1.39TCr
Average	+110.34%	+1.04%	+12,043.54%	+12,167.41%	2.88TCr
Weighted average by Cap.	+0.89%	+0.72%	+56.31%	+157.38%

	2008	2009
Net sales	19.72 16.93 15.89 14.51 27.39 1.88T 27.52 188.04 72.87 949.07 74.06 72.45 3.14T	-
Net income	-3.12Cr -2.68Cr -2.51Cr -2.3Cr -4.33Cr -297.75Cr -4.36Cr -30Cr -12Cr -150.21Cr -12Cr -11Cr -497.52Cr	-3.32Cr -2.85Cr -2.67Cr -2.44Cr -4.61Cr -316.34Cr -4.63Cr -32Cr -12Cr -159.59Cr -12Cr -12Cr -528.59Cr
Net Debt	-29.9 -25.67 -24.09 -22 -41.53 -2.85T -41.73 -285.11 -110.49 -1.44T -112.28 -109.85 -4.77T	2.37 2.04 1.91 1.74 3.29 226.14 3.31 22.6 8.76 114.09 8.9 8.71 377.87

ARYx Therapeutics, Inc. Share Price

Stocks

ARYX

US0433871094

Biotechnology & Medical Research

Valuation : ARYx Therapeutics, Inc.

Press Releases : ARYx Therapeutics, Inc.

Quotes and Performance

Price Extremes

Bio Therapeutic Drugs

Financials

Company Profile

1 day	+1,100.00%
1 week	+1,19,900.00%
Current month	+1,19,900.00%
1 month	+1,19,900.00%
3 months	+1,19,900.00%
6 months	+1,19,900.00%
Current year	+1,19,900.00%